Andere talen MiMedx Group, Inc.

Aandelen

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 25-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
6,79 ^USD	-0,15%		-1,74%	-22,58%

30/04	Transcript : MiMedx Group, Inc., Q1 2024 Earnings Call, Apr 30, 2024
30/04	MiMedx Group, Inc. Rapporteert winstresultaten voor het eerste kwartaal dat eindigde op 31 maart 2024	CI

4 Stocks to Watch in the Booming Regenerative Medicine Market	20/05
MIMEDX to Participate in Upcoming Investor Conferences	15/05
Earnings Flash (MDXG) MIMEDX GROUP Posts Q1 Revenue $84.7M, vs. Street Est of $79.4M	30/04
Earnings Flash (MDXG) MIMEDX GROUP Posts Q1 EPS $0.07, vs. Street Est of $0.04	30/04
MiMedx: Q1 Earnings Snapshot	30/04
MiMedx Group, Inc. Reports Consolidated Impairment for the First Quarter Ended March 31, 2024	30/04
MiMedx Group, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	30/04
MIMEDX Announces First Quarter 2024 Operating and Financial Results	30/04
MIMEDX to Host First Quarter 2024 Operating and Financial Results Conference Call on April 30	16/04
MIMEDX Provides Update on AXIOFILL Request for Designation from FDA	28/03
Merck, Cintas rise; GameStop, MiMedx fall, Wednesday, 3/27/2024	27/03
MiMedx Group Says FDA Affirms Axiofill Falls Short of Regulatory Standards for Tissue-Based Products	27/03
MiMedx Says FDA Still Won't Budge on Axiofill Designation, Files Lawsuit	27/03
MIMEDX Provides Update on AXIOFILL® Request for Designation (“RFD”) from FDA	27/03
MiMedx Group, Inc. Provides Update on AXIOFILL Request for Designation from FDA	27/03
MiMedx Group to Buy Distribution Rights for TELA Bio's Wound Care Product	20/03
MIMEDX Expands Portfolio with Fibrillar Collagen Wound Dressing	20/03
MiMedx Launches E-Commerce Platform	13/03
MIMEDX Introduces E-Commerce and Account Management Platform	13/03
Mimedx Introduces E-Commerce and Account Management Platform	13/03

Geen resultaten voor deze zoekopdracht